Search

Author/Creator Stiff, Patrick J.

1. Evaluation of the International Prognostic Score (IPS‐7) and a Simpler Prognostic Score (IPS‐3) for advanced Hodgkin lymphoma in the modern era. (7th September 2015)

Authors:
Diefenbach, Catherine S.; Li, Hailun; Hong, Fangxin; Gordon, Leo I.; Fisher, Richard I.; Bartlett, Nancy L.; Crump, Michael; Gascoyne, Randy D.; Wagner, Henry; Stiff, Patrick J.; Cheson, Bruce D.; Stewart, Douglas A.; Kahl, Brad S.; Friedberg, Jonathan W.; Blum, Kristie A.; Habermann, Thomas M.; ...
Journal:
British journal of haematology
Issue:
Volume 171:Number 4(2015:Nov.)
Page Start:
530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis. Issue 8 (3rd July 2019)

Authors:
Al-Mansour, Zeina; Li, Hongli; Cook, James R.; Constine, Louis S.; Couban, Stephen; Stewart, Douglas A.; Shea, Thomas C.; Porcu, Pierluigi; Winter, Jane N.; Kahl, Brad S.; Smith, Sonali M.; Marcellus, Deborah C.; Barton, Kevin P.; Mills, Glenn M.; LeBlanc, Michael; Rimsza, Lisa M.; Forman, Stephe...
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 8(2019)
Page Start:
1934
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Issue 29 (10th October 2021)

Authors:
Desai, Pinkal M.; Brown, Janice; Gill, Saar; Solh, Melham M.; Akard, Luke P.; Hsu, Jack W.; Ustun, Celalettin; Andreadis, Charalambos; Frankfurt, Olga; Foran, James M.; Lister, John; Schiller, Gary J.; Wieduwilt, Matthew J.; Pagel, John M.; Stiff, Patrick J.; Liu, Delong; Khan, Irum; Stock, Wendy...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 29(2021)
Page Start:
3261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. (28th September 2021)

Authors:
Riedell, Peter A.; Hamadani, Mehdi; Ahn, Kwang W.; Litovich, Carlos; Brunstein, Claudio G.; Cashen, Amanda F.; Cohen, Jonathon B.; Epperla, Narendranath; Hill, Brian T.; Im, Annie; Inwards, David J.; Lister, John; McCarty, John M.; Ravi Kiran Pingali, Sai; Shadman, Mazyar; Shaughnessy, Paul; Solh...
Journal:
British journal of haematology
Issue:
Volume 195:Number 5(2021)
Page Start:
757
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Issue 14 (5th December 2020)

Authors:
Hagen, Patrick; D'Souza, Anita; Hari, Parameswaran; Davila, Omar; Zhang, Mei-Jie; Vesole, David H.; Smith, Scott E.; Rodriguez, Tulio E.; Stiff, Patrick J.
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 14(2020)
Page Start:
3484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and efficacy of upfront plerixafor + G‐CSF versus placebo + G‐CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non‐Hodgkin's lymphoma or multiple myeloma. Issue 12 (9th September 2013)

Authors:
Micallef, Ivana N.; Stiff, Patrick J.; Stadtmauer, Edward A.; Bolwell, Brian J.; Nademanee, Auayporn P.; Maziarz, Richard T.; Partisano, Angela M.; Marulkar, Sachin; DiPersio, John F.
Journal:
American journal of hematology
Issue:
Volume 88:Issue 12(2013:Dec.)
Page Start:
1017
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Issue 14 (5th December 2020)

Authors:
Hagen, Patrick; D'Souza, Anita; Hari, Parameswaran; Davila, Omar; Zhang, Mei-Jie; Vesole, David H.; Smith, Scott E.; Rodriguez, Tulio E.; Stiff, Patrick J.
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 14(2020)
Page Start:
3484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Outcomes of MYC‐associated lymphomas after R‐CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704. (13th April 2016)

Authors:
Puvvada, Soham D.; Stiff, Patrick J.; Leblanc, Michael; Cook, James R.; Couban, Stephen; Leonard, John P.; Kahl, Brad; Marcellus, Deborah; Shea, Thomas C.; Winter, Jane N.; Li, Hongli; Rimsza, Lisa M.; Friedberg, Jonathan W.; Smith, Sonali M.
Journal:
British journal of haematology
Issue:
Volume 174:Number 5(2016)
Page Start:
686
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗